Your browser doesn't support javascript.
loading
Frequently expressed glypican-3 as a promising novel therapeutic target for osteosarcomas.
Nie, Jun-Hua; Yang, Tao; Li, Hong; Li, Sheng; Li, Ting-Ting; Ye, Hai-Shan; Lu, Meng-Di; Chu, Xiao; Zhong, Guo-Qing; Zhou, Jie-Long; Wu, Mo-Li; Zhang, Yu; Liu, Jia.
Afiliación
  • Nie JH; South China University of Technology School of Medicine, Guangzhou, China.
  • Yang T; Department of Orthopedic Oncology, Guangdong Provincial People's Hospital Affiliated to South China University of Technology School of Medicine, Guangzhou, China.
  • Li H; BioMed Laboratory, Guangzhou Jingke Biotech Group, Guangzhou, China.
  • Li S; BioMed Laboratory, Guangzhou Jingke Biotech Group, Guangzhou, China.
  • Li TT; BioMed Laboratory, Guangzhou Jingke Biotech Group, Guangzhou, China.
  • Ye HS; South China University of Technology School of Medicine, Guangzhou, China.
  • Lu MD; South China University of Technology School of Medicine, Guangzhou, China.
  • Chu X; Department of Orthopedic Oncology, Guangdong Provincial People's Hospital Affiliated to South China University of Technology School of Medicine, Guangzhou, China.
  • Zhong GQ; Department of Orthopedic Oncology, Guangdong Provincial People's Hospital Affiliated to South China University of Technology School of Medicine, Guangzhou, China.
  • Zhou JL; Department of Orthopedic Oncology, Guangdong Provincial People's Hospital Affiliated to South China University of Technology School of Medicine, Guangzhou, China.
  • Wu ML; Liaoning Laboratory of Cancer Genomics and Epigenomics, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
  • Zhang Y; Department of Orthopedic Oncology, Guangdong Provincial People's Hospital Affiliated to South China University of Technology School of Medicine, Guangzhou, China.
  • Liu J; South China University of Technology School of Medicine, Guangzhou, China.
Cancer Sci ; 113(10): 3618-3632, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35946078

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Óseas / Osteosarcoma / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Sci Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Óseas / Osteosarcoma / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Sci Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido